Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersNephrology Physician in Cleveland, OH
NPI: 1083865802Primary Practice Location
UH CLEVELAND MEDICAL CENTER
11100 Euclid Ave, Cleveland, OH
Primary Employer
University Hospitals Medical Group Inc
uhhospitals.org
HQ Phone
Get M.D. Mirela's Phone Numberphone_androidMobile
Get M.D. Mirela's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 56 | 136 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 27 | 49 |
| 3 | 90935Hemodialysis procedure with one physician evaluation | 24 | 55 |
| 4 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 20 | 23 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 17 | 20 |
Safety of SGLT2 Inhibitors in CKD: Walking the Fine Line.
Authors: @ValidYN, LastName, ForeName, Initials, Identifier, AffiliationInfo
Journal: Clin J Am Soc Nephrol
Publication Date: 2022-05-26
Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials.
Authors: Martin Schreiber, Sankar Navaneethan
Publication Date: 2010-09-30
Lead Sponsor: University Hospitals Cleveland Medical Center
Collaborators: University of Maryland, University of Toronto, Winthrop University
Intervention / Treatment: DRUG: Placebo, DRUG: Spironolactone
Lead Sponsor: University Hospitals Cleveland Medical Center
Collaborators: Relypsa, Inc.
Intervention / Treatment: DRUG: Spironolactone
